Search - tctmd.com

Displaying 161 - 180 of 1445

Sort: Relevancy | Date

News Daily News

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Caitlin E. Cox

June 21, 2024

News Conference News NY Valves 2024

National Data Point to Soaring TAVI Rates in Patients Under 65

Michael O'Riordan

June 14, 2024

News Conference News NY Valves 2024

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

Michael O'Riordan

June 11, 2024

News Conference News NY Valves 2024

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

Todd Neale

June 07, 2024

Presentation NY Valves 2024

Seeing Is Believing: The Importance of Imaging of CIEDs in Lead-Tricuspid Valve Interactions

Presenter: Elana Koss

June 07, 2024

News Conference News NY Valves 2024

Risk Score IDs Patients Safe for Same-Day Discharge After Low-Risk TAVI

Michael O'Riordan

June 06, 2024

News Conference News NY Valves 2024

Essentials for 3D-ICE in Structural Interventions Explored in Position Statement

Caitlin E. Cox

June 06, 2024

Presentation NY Valves 2024

AI-Powered Cardiac Ultrasound Improves Identification of High-Risk Aortic Stenosis (EchoIQ)

Presenter: Pedro Covas

June 05, 2024

Presentation NY Valves 2024

Keynote Lecture: AI-Powered Multimodality Cardiac Imaging in Valvular Heart Disease: From Screening to Intervention

Presenter: Partho P. Sengupta

June 05, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Daily News

AI-Assisted Look at Coronary Inflammation on CT Refines CV Risk Assessment

Todd Neale

May 31, 2024

News Industry News

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

May 29, 2024

News Conference News EuroPCR 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Yael L. Maxwell

May 17, 2024

News Conference News EuroPCR 2024

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

Michael O'Riordan

May 16, 2024

News Conference News EuroPCR 2024

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

Shelley Wood

May 16, 2024

News Conference News EuroPCR 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Michael O'Riordan

May 15, 2024

Presentation EuroPCR 2024

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Presenter: Ole De Backer

May 15, 2024

Presentation EuroPCR 2024

Short Methodology Insight - NOTION-2

Presenter: Davide Capodanno

May 14, 2024

News Daily News

Certain Periprocedural MIs Don’t Matter, New Data Allege

Michael O'Riordan

May 09, 2024

News Industry News

Biosense Webster Launches New Version of CARTO™ 3 Electro-Anatomical Mapping System

May 08, 2024

Advertisement

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

National Data Point to Soaring TAVI Rates in Patients Under 65

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

Seeing Is Believing: The Importance of Imaging of CIEDs in Lead-Tricuspid Valve Interactions

Risk Score IDs Patients Safe for Same-Day Discharge After Low-Risk TAVI

Essentials for 3D-ICE in Structural Interventions Explored in Position Statement

AI-Powered Cardiac Ultrasound Improves Identification of High-Risk Aortic Stenosis (EchoIQ)

Keynote Lecture: AI-Powered Multimodality Cardiac Imaging in Valvular Heart Disease: From Screening to Intervention

June 2024 Dispatch for the CV Team

AI-Assisted Look at Coronary Inflammation on CT Refines CV Risk Assessment

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Short Methodology Insight - NOTION-2

Certain Periprocedural MIs Don’t Matter, New Data Allege

Biosense Webster Launches New Version of CARTO™ 3 Electro-Anatomical Mapping System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content